Limitation on cost-sharing obligation for insulin covered under benefit contract covering prescription insulin drugs.

1. A society that offers or issues a benefit contract which provides coverage for prescription insulin drugs shall not impose against an insured a deductible, copayment, coinsurance or other cost-sharing obligation that is greater than $35 for a 30-day supply of a prescription insulin drug which is prescribed to the insured and covered by the society, regardless of the amount or type of prescription insulin drug prescribed. 2. As used in this section: (a) “Diabetes” includes type I, type II and gestational diabetes. (b) “Prescription insulin drug” means a prescription drug that contains insulin and is used to control blood glucose levels for the purpose of treating diabetes. (Added to NRS by 2025, 1827)